HARROW, INC. — Director's Dealing 2023

Apr 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2023-04-03

Reporting Person: SAHAREK JOHN P. (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-03	Restricted Stock Unit	$	A	277200	Acquired	2028-04-03	Common Stock (277200)	Direct

Footnotes

F1: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 39,600 PSU shares), $35 (causing the vesting of 59,400 PSU shares), $45 (causing the vesting of 79,200 PSU shares), $50 (causing the vesting of 99,000 PSU shares).